Catheter Precision Ownership

VTAK Stock   0.35  0.02  5.41%   
Catheter Precision shows 13.52 percent of its outstanding shares held by insiders and 4.66 percent owned by other corporate entities.
 
Shares in Circulation  
First Issued
2017-03-31
Previous Quarter
757.3 K
Current Value
2.1 M
Avarage Shares Outstanding
1.2 M
Quarterly Volatility
2.3 M
 
Covid
Some institutional investors establish a significant position in stocks such as Catheter Precision in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Catheter Precision, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The value of Dividends Paid is estimated to slide to about 725.7 K. The value of Dividend Paid And Capex Coverage Ratio is expected to slide to -284.87. Common Stock Shares Outstanding is expected to rise to about 5.8 M this year, although the value of Net Loss will most likely fall to (30.3 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.

Catheter Stock Ownership Analysis

About 14.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.23. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Catheter Precision recorded earning per share (EPS) of 30.61. The entity last dividend was issued on the 17th of November 2020. The firm had 1:10 split on the 15th of July 2024. For more information please call David Jenkins at 973-691-2000 or visit https://www.catheterprecision.com.
Besides selling stocks to institutional investors, Catheter Precision also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Catheter Precision's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Catheter Precision's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Catheter Precision Quarterly Liabilities And Stockholders Equity

26.75 Million

About 14.0% of Catheter Precision are currently held by insiders. Unlike Catheter Precision's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Catheter Precision's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Catheter Precision's insider trades

Catheter Precision Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Catheter Precision insiders, such as employees or executives, is commonly permitted as long as it does not rely on Catheter Precision's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Catheter Precision insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Catheter Precision is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catheter Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catheter Precision Stock. Highlighted below are key reports to facilitate an investment decision about Catheter Precision Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
30.61
Revenue Per Share
0.604
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.22)
Return On Equity
(0.50)
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.